-
Anyone who had been patient enough and build a position under .09 the past couple of weeks was rewarded today. The stock gaped up 15%.
ACTC Technology has been recently featured in USA Today, Newsweek, and Scientific American. My guess is that a few reporters at the recent Insurance Linked Securities Summit took notice of ACTC's operations and wanted to dig a little deeper into the stem cell world.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules